Agent delivery system capable of selectively releasing an agent
View Patent ↗The present invention provides a composition for selectively delivering an active agent to a portion of an organism. The composition comprises first and second polymer portions, having first and second functional groups attached as a side-chain thereto, respectively. The first and second functional groups form cross-links between the first and second polymer portions. The cross-links are capable of being broken by a substance of the organism, thereby resulting in release of the active agent. The composition provides a novel means for controlling the selective release of the active agent in the organism.
1. A modified or isolated composition, comprising:
a gel formed from:
first polymers having first functional groups comprising a first nucleic acid sequence attached as side-chains thereto; and
second polymers having second functional groups comprising a second nucleic acid sequence attached as side-chains thereto, said first and said second functional groups form reversible cross-links between said first and said second polymers, wherein said cross links comprise a plurality of hydrogen bonds between complementary base portions of said first and said second nucleic acid sequences; and
further including therein said gel an active agent disposed between said first and second polymers, said active agent capable of being released by an interaction of a substance with said first or said second nucleic acid sequences to thereby break said cross-links, wherein:
said first and second polymers are separate polymers and said first and second polymers are held together by said hydrogen bonds,
said gel is in a solid state when said cross-links are unbroken, and
said gel is in a fluid state when said cross-links are broken.
2. The composition as recited in claim 1 , wherein said substance is an enzyme capable of breaking said cross-links by a cleavage of said first and said second nucleic acid sequences.
3. The composition as recited in claim 2 , wherein said enzyme is selected from the group consisting of nucleases and ribozymes.
4. The composition as recited in claim 3 , wherein said nuclease is a exodeoxyribonuclease, exoribonuclease, endodeoxyribonuclease, or endoribonuclease as classified according International Union of Biochemistry and Molecular Biology enzyme nomenclature categories EC 3.1.11 to EC 3.1.31.
5. The composition as recited in claim 1 , wherein said substance comprises a third nucleic acid sequence and at least one of said first nucleic acid sequence or said second nucleic acid sequence further comprise a nucleic acid sequence, wherein said third nucleic acid sequence is sufficiently complementary to a portion of said nucleic acid sequence such that said third nucleic acid sequence causes a dissociation of said cross-links.
6. The composition as recited in claim 1 , further includes a third nucleic acid sequence capable of attaching to said first and said second nucleic acid sequences to facilitate formation of said cross-links.
7. The composition as recited in claim 6 , wherein said substance is an enzyme capable of breaking said cross-links by a cleavage of said third nucleic acid sequence.
8. The composition as recited in claim 6 , wherein said substance is a fourth nucleic acid sequence and said third nucleic acid sequence comprises a nucleic acid sequence, wherein said fourth nucleic acid sequence is sufficiently complementary to said nucleic acid sequence to cause a dissociation of said cross-links.
9. The composition as recited in claim 1 wherein said active agent is selected from the group consisting of:
a protein; and
a nucleic acid sequence.
10. The composition as recited in claim 1 , wherein said active agent comprises a nucleic acid sequence.
11. The composition as recited in claim 6 , wherein said active agent comprises a nucleic acid sequence released from said first or said second nucleic acid sequence.
12. The composition as recited in claim 1 , wherein said active agent comprises drugs.
13. The composition as recited in claim 1 , wherein said active agent comprises antibiotics.